MOBISTA
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Jul 2024)
What this means for you
This application is over — abandoned 29 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90262583
- Mark type
- Stylized text
- Filed
- 19 Oct 2020
- Published for opposition
- 27 Apr 2021
- Abandoned
- 29 Jul 2024
- Attorney of record
- Vanessa A. Ignacio, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of human diseases and medical conditions, namely, cancer, infections, infectious diseases, inflammatory disorders, immune system disorders, autoimmune disorders and transplant rejection; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors for stem cells in stem cell mobilization, immune system stimulators and immune system modulators; Diagnostic agents, preparations and substances for medical purposes
Owner
- Celldex Therapeutics, Inc., Hampton, NJ, US
- Celldex Therapeutics, Inc., Hampton, NJ, US
Prosecution history
- 29 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 12 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Dec 2023 — SOU EXTENSION 5 GRANTED
- 01 Dec 2023 — SOU EXTENSION 5 FILED
- 11 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 27 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 May 2023 — SOU EXTENSION 4 GRANTED
- 25 May 2023 — SOU EXTENSION 4 FILED
- 25 May 2023 — SOU TEAS EXTENSION RECEIVED
- 01 Dec 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2022 — SOU EXTENSION 3 GRANTED
- 29 Nov 2022 — SOU EXTENSION 3 FILED
- 29 Nov 2022 — SOU TEAS EXTENSION RECEIVED